Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2000
12/13/2000CN1276221A Anal fissure ointment and its preparing process
12/13/2000CN1276218A Secondary dissolving-in method for preparing 'Zhuifeng Zhentong' plaster for alleviating pain
12/13/2000CN1276216A Process for preparing non-decoction Chinese medicine
12/13/2000CN1276208A Formaldehyde injection for treating infective diseases of animal
12/13/2000CN1276207A Chinese-medicinal aerosol for treating coronary heart disease and angina pectoris
12/13/2000CN1059338C Chinese medicine for treating cerebral vascular diseases and its producing method
12/13/2000CN1059330C Use of sophora fruit in medicine for treatment of tonsillitis
12/13/2000CN1059328C Hair regrowth liquid medicine
12/13/2000CN1059327C Plaster for treatment of child asthma
12/13/2000CN1059326C Nutrient tea
12/13/2000CN1059323C Chinese medicine for treating phinitis diseases
12/13/2000CN1059320C Sugar-free sarcandra glabra lozenge
12/13/2000CN1059319C Cosmetic and/or dematological composition with hydrophilic carrier and vitamine C which can be mixed before use
12/12/2000US6160165 Preparing a stirred slurry of pamidronate in water, adding a solution of sodium hydroxide to give a clear solution at ph of about 6.5, filtering, freezing and lyophilizing the solution to form amorphous anhydrous disodium pamidronate
12/12/2000US6160161 Used as anti-thrombosis agents or as surfactants or cosurfactants for phospholipids intended for the preperation or stabilization of fluorocarbon emulsions, specially for biomedical applications
12/12/2000US6160019 Dissolving 0.1 to 10% w/v of nimesulide in 2 to 90% w/v of dimethylacetamide to form a solution, adding benzyl alcohol, polyethylene glycol, hydrochloric acid, propylene glycol
12/12/2000US6160007 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
12/12/2000US6159977 Therapeutic anti-fungal nail preparation
12/12/2000US6159958 Treatment or prophylaxis of retinal pathology and spinal cord injury
12/12/2000US6159955 Use of hyaluronic acid and a NSAID for the manufacture of a medicament for the treatment of mucosal diseases
12/12/2000US6159952 Bronchodilator agents
12/12/2000US6159943 Use of ribose to prevent cramping and soreness in muscles
12/12/2000US6159933 Emulsion preconcentrate comprising a cyclosporin, propylene carbonate, and glycerides
12/12/2000US6159931 Reaction of insulin with aldehyde and reducing agent and purification
12/12/2000US6159728 Capsid formed from a coat protein of a bacteriophage and enclosing a foreign moiety linked to an rna sequence of a bacteriophage translational operator which binds to the coat protein; drug delivery; gene therapy
12/12/2000US6159504 Producing, by electrostatic attraction, micro calcium-containing shells on the surfaces of droplets of an emulsion comprising oil; replacing oil with other solvent, drying, introducing core substance into the hollow
12/12/2000US6159502 Oral delivery systems for microparticles
12/12/2000US6159501 Modified release multiple-units dosage composition for release of opioid compounds
12/12/2000US6159500 Pharmaceutical preparations of glutathione and methods of administration thereof
12/12/2000US6159499 Composition containing an acid-labile benzimidazole and process for its preparation
12/12/2000US6159498 Water-soluble delivery device for application to mucosal surfaces
12/12/2000US6159497 Patch applicator
12/12/2000US6159495 Used as a wound dressing, a tissue-engineering scaffold, a diffusion membrane, a coating for implantable devices, a cell encapsulant, and a cross-linked implantable biomaterial for soft and hard tissue replacement
12/12/2000US6159494 Treatment of post operative scars with a tape containing a gel from Bulbine frutescens
12/12/2000US6159493 Comprising polyvinyl alcohol solution, polyvinyl pyrrolidone, and excipient
12/12/2000US6159492 Drug storage and delivery system containing a medicated lollipop
12/12/2000US6159491 Prolonged release bioadhesive vaginal gel dosage form
12/12/2000US6159490 Pharmaceutical implant for the delivery of an effective amount of a bioactive peptide or peptide analog over a period of 1 to 12 months
12/12/2000US6159485 Cosmetics; skin disorders
12/12/2000US6159479 Clear, aqueous solution containign polyoxyethylene oxide solubilizer
12/12/2000US6159473 Sore throat spray
12/12/2000US6159458 Sustained release ophthalmic compositions containing water soluble medicaments
12/12/2000US6159450 Use of Ginkgo biloba flavonoidic extract substantially devoid of terpenes for oral hygiene and composition containing such extract
12/12/2000US6159449 Liquid mixture of calcium compound and halogen compound
12/12/2000US6159443 X-ray guided drug delivery
12/12/2000US6159143 Method and device for delivery of therapeutic agents in conjunction with isotope seed placement
12/12/2000CA2168247C Nitric oxide donor composition and method for treatment of anal disorders
12/12/2000CA2065084C Sustained release capsule and formulations
12/12/2000CA2046997C Liposomal products
12/12/2000CA2029383C Swelling modulated polymeric drug delivery device
12/12/2000CA2021307C Low friction film dressing
12/11/2000CA2274419A1 Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments
12/07/2000WO2000073482A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
12/07/2000WO2000073471A1 Cationic lipids for gene transfer and preparation method thereof
12/07/2000WO2000073335A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy
12/07/2000WO2000073263A1 Cytofectin dimers and methods of use thereof
12/07/2000WO2000072955A1 Method for producing morphologically uniform micro and nanoparticles using micromixers
12/07/2000WO2000072953A2 A method of producing organic emulsifiers and organic surfactants, products produced by said method, and the use of such products
12/07/2000WO2000072902A1 Enhanced thawing of biopharmaceutical solutions using oscillatory motion
12/07/2000WO2000072884A1 A novel formulation of n-(4-nitro-2-phenoxyphenyl)methanesulfonamide
12/07/2000WO2000072883A2 Pharmaceutical transdermal compositions
12/07/2000WO2000072873A1 Freeze dried hgf preparations
12/07/2000WO2000072872A1 Keratinocyte growth factor-2 formulations
12/07/2000WO2000072871A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
12/07/2000WO2000072870A1 Compositions of a-beta peptide and processes for producing same
12/07/2000WO2000072867A2 Substantially oil-free cyclosporin compositions
12/07/2000WO2000072861A1 Pharmaceutical preparations of bioactive substances extracted from natural sources
12/07/2000WO2000072860A1 Wound healing article comprising dried and crushed leaves from plantago major
12/07/2000WO2000072859A1 Balsam for the treatment of surface burns and chafing rashes
12/07/2000WO2000072857A1 Fibrin polymer structure
12/07/2000WO2000072855A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
12/07/2000WO2000072851A1 Method of sterilizing
12/07/2000WO2000072848A1 Composition comprising (±)-5-ethyldihydro-5-(1-methylbutyl)-2-thioxo 4,6(1h,5h)-pyrimidinedione dissolved in 2,5-di-o-methyl-1,4:3,6-dianhydro-d-glucitol
12/07/2000WO2000072847A1 Ziprasidone suspension
12/07/2000WO2000072842A1 Nutritional supplements
12/07/2000WO2000072839A1 Antiseptic spermicidal composition and means for its application
12/07/2000WO2000072831A1 Nutritional formulations
12/07/2000WO2000072830A1 Method of producing submicron particles of a labile agent
12/07/2000WO2000072829A1 Novel formulations comprising lipid-regulating agents
12/07/2000WO2000072828A1 A method of tabletting dose units of active agents
12/07/2000WO2000072827A2 Porous drug matrices and methods of manufacture thereof
12/07/2000WO2000072826A1 Formulation and method for preparing elementary units from fermented drink
12/07/2000WO2000072825A1 Novel formulations comprising lipid-regulating agents
12/07/2000WO2000072824A1 Microliposomes and process for producing the same
12/07/2000WO2000072823A1 Preparations for the application of anti-inflammatory agents
12/07/2000WO2000072822A1 Preparations for the application of anti-infective and/or anti-inflammatory agents
12/07/2000WO2000072821A1 Generation of therapeutic microfoam
12/07/2000WO2000072820A2 Injectable anesthetic formulation
12/07/2000WO2000072806A2 Sunscreen composition containing sol-gel microcapsules
12/07/2000WO2000072757A1 Surface stabilized microbubbles for use in ultrasound contrast and drug delivery agents
12/07/2000WO2000072701A1 Method and composition for masking mineral taste
12/07/2000WO2000072679A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues
12/07/2000WO2000050035A3 Premixed formulation of piperacillin sodium and tazobactam sodium injection
12/07/2000WO2000050018A3 Pharmaceutical preparation containing dithranol
12/07/2000WO2000048626A3 Aerosol compositions of hmg-coa reductase inhibitors for inhibiting inflammation associated with pulmonary disease
12/07/2000WO2000047166A3 Microemulsion containing alkano lammonium salts of fatty alcohol sulfates and/or alkylpoly alkylene glykol ether sulfates
12/07/2000WO2000046147A3 Therapeutic calcium phosphate particles and methods of manufacture and use
12/07/2000WO2000045849A3 Use of cationic lipids to generate anti-tumor immunity
12/07/2000WO2000045801A3 Use of a nitrate vasodilator alone or in combination with capsaicin for the treatment of pain
12/07/2000WO2000045790A3 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles